| Christine Elaine Desmond, MD | |
|
949 Bridgeport Ave, Milford, CT 06460-3142 | |
| (203) 878-6365 | |
| Not Available |
| Full Name | Christine Elaine Desmond |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 949 Bridgeport Ave, Milford, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114025962 | NPI | - | NPPES |
| 004039244 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 060365 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Elaine Desmond, MD 116 Towpath Ln, Cheshire, CT 06410-3313 Ph: (203) 272-2156 | Christine Elaine Desmond, MD 949 Bridgeport Ave, Milford, CT 06460-3142 Ph: (203) 878-6365 |
News Archive
People are falling into a trap of greater inactivity during middle age, according to new research from The University of Texas Health Science Center at Houston, which calls for its findings to be considered in future national physical activity guidelines.
In a test of antiviral effectiveness against the virus that causes COVID-19, an extract from edible seaweeds substantially outperformed remdesivir, the current standard antiviral used to combat the disease.
Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.
HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of the International Journal of Radiation Oncology•Biology•Physics, an official journal of the American Society for Radiation Oncology.
InterMune today announced that patient enrollment has begun in ASCEND, a new Phase 3 study of pirfenidone for patients who suffer from idiopathic pulmonary fibrosis.
› Verified 4 days ago
Dr. Ubong Jackson Udoyen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 58 Augusta Dr, Milford, CT 06461 Phone: 803-269-7381 | |
Dr. Howard Feldman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 16 Rock Rd, Milford, CT 06460 Phone: 203-874-0895 | |
Terrell David Holloway, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 472 Wheelers Farms Rd Ste 306, Milford, CT 06461 Phone: 203-701-9737 | |
Donna W Klimowicz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 949 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-6365 | |
Dr. Burton G. Austen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 75 New Haven Avenue, Milford, CT 06460 Phone: 212-614-1011 Fax: 203-389-9896 | |
Lisa Harding, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 472 Wheelers Farms Rd Ste 306, Milford, CT 06461 Phone: 563-676-8923 Fax: 859-545-5013 |